FDA Investigator Santiago Gallardo Johnson

Santiago Gallardo Johnson has inspections in 4 countries as of 12 Oct 2023. Santiago Gallardo Johnson has collaborated with a combinined 4788 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

12 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100005290

Country:

United States of America, Australia, Japan, Germany

Co-Investigator(s):

Adam R Cooke, Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Albert C Cheng, Alexandra B Pitkin, Allison A Rodriguez, Amanda L Fyles, Amir Alavi, Andrew Le, Andrew S Limson, Anita Narula, PhD, Anthony A Charity, Arsen Karapetyan, Ashley N Queen, PhD, Azza Talaat, Babajide Michael Osunsanmi, Bichsa T Tran, Binh T Nguyen, Brien C Fox, Bruce H Mccullough, Bryan A Galvez, Calvin B Koerner, Carla J Lundi, Carolina D Vasquez, Caroline H Le, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cecilia H Kieu, Chani Broner, PhD, Chelsea N Sealey, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher M Hernandez, Christopher M Jenner, Christopher M Reed, Christopher R Czajka, Christopher S Keating, Claudia Mperez Kasmarski, Comyar Shoghi, Crystal Monroy, Cynthia Jim, CSO, Daniel J Lahar, Darla J Christopher, Darren S Brown, Darrin E Davis, David G Whitman, Deborah A Greco, Debra I Love, Dennis Cantellops Paite, Devon Jenkins, Diana M Rand, Diane Cvan Leeuwen, Djamila Harouaka, Donna Mwilliams Hill, Dr. Chunchang Fang, Dyana K Stone, Eileen A Liu, Elizabeth D Gonzales, Emilie E Kahn, Erika V Butler, Esteban Beltran, Esther B Gamallo Herrera, Esther Bgamello Herrera, Esther C Broner, PhD, Finn A Slizza, Francis A Guidry, Frederick Fricke, Frederick L Fricke, Gabriel Guevarra, Gabriel M Guevarra, Gam S Zamil, Gene D Arcy, Geraldine H Matining, Geraldine M Peregrin, Gerard T Schneider, Ginger M Sykes, Glen C Lawrence, Grace Deneke, Grace E Mcnally, Grace P Santos, Gregory A Berg, Gunneet Kaur, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Heidy C Perales, Helen B Ricalde, Isabel Y Espinosa, Jacqueline Mdiaz Albertini, Jai P Singh, James B Arnett, James L Dunnie, Jr, James M Timper Jr, James R Montero, Jamie L Dion, Janet Blount, Janet D Bart, Jasmine N Thompson, Jazmine M Welcher, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer M Gogley, Jeremy Beber, Jeremy H Nguyen, Jessie E Morris, Joan A Loreng, Joe X Phillips, Joey V Quitania, John A Gonzalez, John P Jorgensen, Jolanna A Norton, Jonathan R Campos, Joseph X Phillips, Juan A Morales, Karen A Wolnik, Karen G Hirshfield, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathy Chiu, Kathy Kuo, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kham Phommachang, Kham Phommachanh, Kim Lthomas Cruse, Kim Thomas Chase, Kimberley A Hoefen, Kumar G Janoria, Langer, Lata C Mathew, PhD, LCDR Chad N Thompson, Lestine C Webb, Lewis K Antwi, Lilly O Barton, Linda F Murphy, Linda M Cheny, Linda Thai, Linda Than, Lisa Shin, Lixia Cai, LT Richard A Lyght, Lucas B Leake, Luis M Burgos, Luis M Burgos Medero, Marc A Jackson, Jr, Marco S Esteves, Marcus F Yambot, Margaret M Annes, Marianela Aponte Cruz, Marie Bbuen Bigornia, Marie T Falcone, Marijo B Kambere, PhD, Marion W Nadeau, Mariza M Jafary, Mariza M Jalary, Mark A Tucker, Marlene G Swider, Marlo Ianm Alintanahin, Mary Ewilkerson Brinsko, Mary Jeanet Mcgarry, Matthew B Casale, Matthew J Johnson, Matthew R Clabeaux, Matthew R Dionne, Michael A Charles, Michael D Garcia, Michael E Maselli, Michael J Kuchta, Michael R Goga, Michael S Araneta, Michael Shanks, MS, Michael T Cyrus, Mihaly S Ligmond, Minh D Phan, Nancy G Schmidt, Nayan J Patel, Nicholas A Violand, Nicholas L Hunt, Omotunde O Osunsanmi, Pabhu P Raju, Patricia A Brown, Patricia A Cortez, Patricia D Stahnke, Patricia F Alberico, Paul A Bonneau, Phillip L Toy, Prabhu P Raju, Rachel C Stanton, Raymond T Oji, Rebecca K Olin, Richmond K Yip, Ricki A Chase, Ricki Achase Off, Robert D Tollefsen, Robert J Martin, Roger F Zabinski, Roger L Farmer, Rose Xu, Rowena S Nguyen, Rumany C Penn, PharmD, Ryan J Borges, Saied A Asbagh, Samantha J Bradley, Samina S Khan, Sangeeta M Khurana, PhD, Santos E Camara, Scott K Zika, Scott N Lim, Sean P Desbrow, Selene T Torres, Seneca D Toms, Shannon B Ruelle, Shelley H Beausoleil, Sidney B Priesmeyer, Simone E Pitts, Sonya L Karsik, Sparky L Bartee, Stephanie A Slater, MS, Steve Y Rhieu, PhD, Steven C Madzo, Sundy V Sedwick, Sundy Ven, Susan M Jackson, Susant Hadman, Taichun Qin, PhD, Tajah L Blackburn, Tamala P Bogan, Tamala P Magee, Tamara L Setzer, Tara L Breckenridge, Tara L Greene, Ted L Anderson, Terrance P Nguyen, Terri L Dodds, Thanh M Andrews, Thao T Kwan, Theresa Kirkham (NMI), Theressa B Smith, Thomas J Arista, Thomas R Beilke, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vanessa R Muller, Vashti E Bocker, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Walden H Lee, Walden Lee, Wayne W Grundstrom, Wenzheng Zhang, Xiaohui Shen, Yasamin Ameri, Yi Wang, PhD, Yumi J Hiramine, Yvette E Guillermo, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Santiago Gallardo Johnson's Documents

Publish Date	Document Type	Title
February, 2018	FDA 483 Response	Samson Pharmaceuticals, Inc. - Form 483R, 2018-02-20
August, 2021	FDA 483	Teva Parenteral Medicines, Inc. - Form 483, 2021-08-20
August, 2019	EIR	Polypeptide Laboratories Inc - EIR, 2019-08-30
October, 2019	FDA 483	Botanical Resources Australia-Manufacturing Services Pty Ltd - Form 483, 2019-10-11
April, 2021	EIR	Societal CDMO San Diego, LLC - EIR, 2021-04-07
January, 2018	FDA 483	ACTA LABORATORIES - Form 483, 2018-01-19
October, 2017	FDA 483	University Rx Specialist, dba University Compounding Pharmacy - Form 483, 2017-10-27
January, 2018	EIR	ACTA LABORATORIES - EIR, 2018-01-19
February, 2019	EIR	Bachem Americas, Inc. - EIR, 2019-02-05
April, 2021	FDA 483 Response	Societal CDMO San Diego, LLC - Form 483R, 2021-04-28
December, 2017	FDA 483 Response	TOLMAR INC - Form 483R, 2018-01-03
September, 2019	EIR	Nitto Avecia Pharma Services, Inc. - EIR, 2019-09-20
December, 2019	FDA 483 Response	Ajinomoto Althea, Inc. - Form 483R, 2019-12-20
December, 2021	FDA 483	Genlabs Corporation - Form 483, 2021-12-09
December, 2019	EIR	Ajinomoto Althea, Inc. - EIR, 2019-12-20
April, 2021	FDA 483	Societal CDMO San Diego, LLC - Form 483, 2021-04-07
July, 2022	FDA 483	U.S. Continental Marketing, Inc. - Form 483, 2022-07-21
August, 2019	FDA 483	Polypeptide Laboratories Inc - Form 483, 2019-08-30
April, 2019	FDA 483	Diamond Wipes International, Inc. - Form 483, 2019-04-19
May, 2021	FDA 483	Ajinomoto Althea, Inc. - Form 483, 2021-05-25
March, 2018	FDA 483	Pacira Pharmaceuticals, Inc. - Form 483, 2018-03-01
October, 2021	FDA 483	TG Labs, Inc. - Form 483, 2021-10-29
August, 2019	FDA 483 Response	Polypeptide Laboratories Inc - Form 483R, 2019-09-13
August, 2019	EIR	Ajinomoto Althea, Inc. - EIR, 2019-08-07
September, 2022	FDA 483	Meiji Seika Pharma Co., Ltd. - Form 483, 2022-09-02
March, 2018	EIR	Pacira Pharmaceuticals, Inc. - EIR, 2018-03-01
August, 2018	FDA 483	Fill it Pack It Inc - Form 483, 2018-08-08
July, 2017	FDA 483	Polypeptide Laboratories Inc - Form 483, 2017-07-19
December, 2017	FDA 483	TOLMAR INC - Form 483, 2017-12-06
February, 2018	FDA 483	Samson Pharmaceuticals, Inc. - Form 483, 2018-02-09
October, 2018	FDA 483	San Diego Compounding Pharmacy - Form 483, 2018-10-25
May, 2018	FDA 483	220 Laboratories LLC. - Form 483, 2018-05-17
December, 2017	EIR	TOLMAR INC - EIR, 2017-12-06
October, 2019	FDA 483	Mayne Pharma International Pty Ltd. - Form 483, 2019-10-18
December, 2019	FDA 483	Ajinomoto Althea, Inc. - Form 483, 2019-12-20
August, 2019	FDA 483	Ajinomoto Althea, Inc. - Form 483, 2019-08-07
January, 2020	FDA 483	Samson Pharmaceuticals, Inc. - Form 483, 2020-01-29
March, 2018	EIR	Nelson Laboratories, LLC - EIR, 2018-03-30
August, 2019	FDA 483	Southern California Compounding Pharmacy, LLC - Form 483, 2019-08-01
November, 2022	FDA 483	Hyland's Consumer Health Inc. - Form 483, 2022-11-29
August, 2021	FDA 483 Response	Teva Parenteral Medicines, Inc. - Form 483R, 2021-09-13
January, 2023	FDA 483	Societal CDMO San Diego, LLC - Form 483, 2023-01-25
April, 2019	EIR	Sterigenics Radiation Technologies, LLC - EIR, 2019-04-26
September, 2022	FDA 483	Daito Pharmaceutical Co., Ltd - Form 483, 2022-09-16
September, 2022	FDA 483	Ishihara Sangyo Kaisha, Ltd. - Form 483, 2022-09-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more